The Phase 1b study will evaluate LV UNO in unresectable cutaneous or subcutaneous histologically confirmed primary or metastatic solid tumor cancer patients that have progressed or have prolonged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback